Benign Prostatic Hyperplasia

Treatment is updated daily with the most recent articles listed on top.
To view only the last month's articles for the other sub-topics, go to our Monthly Online Newsletters page

Also review Related Articles: Prostatitis and Prostate Cancer.

If you have any questions regarding our Search Reports, please contact us at info@infomedsearch.com.

CONTINUE YOUR INFOMEDSEARCH RESEARCH with our previous InfoMedLinks. Start with InfoMedLinks 2006.

Benign Prostatic Hyperplasia

General Information

NEWS:

ARTICLES:

BPH: Every Man's Problem: Enlarged Prostate (BPH): A Complex Problem "When the bladder does not empty completely, you become at risk for developing urinary tract infections. Other serious problems can also develop over time, including bladder stones, blood in the urine, incontinence, and acute urinary retention (an inability to urinate). A sudden and complete inability to urinate is a medical emergency; you should see your doctor immediately. In rare cases, bladder and/or kidney damage can develop from BPH."

JOURNAL ARTICLES:

A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting. (Int J Clin Pract. 2007)

An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function. (BJU Int. 2007 )

Associations Between Diabetes and Clinical Markers of Benign Prostatic Hyperplasia among Community-Dwelling Black and White Men. (Diabetes Care. 2007) “Taken together, our findings suggest that the presence of diabetes may be less related to prostate growth and more related to the dynamic components of lower urinary tract function. Further evaluations of the association between diabetes and BPH and related racial variations are warranted.”

[Benign prostatic hyperplasia and neurourology] (Prog Urol. 2007)

[Importance of nocturia and its impact on quality of sleep and quality of life in patient with benign prostatic hyperplasia] (Actas Urol Esp. 2007) "CONCLUSIONS: Nocturia is a symptom with a high prevalence in older patients with STUI/BPH. The PreNoc study has showed a Nocturia prevalence in Spain of 83% in patients > or =60 years old diagnosed of BPH. Nocturia is the most bothersome symptom in patients with STUI/BPH."

Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment. (Int J Impot Res. 2007)

Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines. (Yonsei Med J. 2007) "CONCLUSION: These data provide a picture of current practices regarding the management of BPH in Korea. The diagnostic and treatment practices for BPH do not follow published guidelines. Our findings ask the question "How influential are international guidelines, and do they really affect patient management in countries that do not have country-specific guidelines?""

Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications. (Int J Impot Res. 2007)

Practice patterns regarding prostate cancer and benign prostatic hyperplasia in Japanese primary care practitioners. (Int J Urol. 2007)

Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting. (Int J Clin Pract. 2007) "Conclusions: Although a significant percentage of men in this older population had enlarged prostate and LUTS, only one-third of them intended to discuss their symptoms with their physician. PCPs may need to increase efforts to detect LUTS and enlarged prostate in older men."

Rising PSA in patients with minor LUTS without evidence of prostatic carcinoma: a missing link? (Int Urol Nephrol. 2007) "CONCLUSIONS: An increased PSA in patients with minor or no LUTS, clinical BPH and negative extended multi-site prostate biopsy is strongly correlated to bladder outlet obstruction. Therefore, patients with these characteristics should be treated with TURP."

The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. (J Urol. 2007)

Go to the top